Jpmorgan Chase & CO Arcturus Therapeutics Holdings Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 203,607 shares of ARCT stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
203,607
Previous 203,607 -0.0%
Holding current value
$1.48 Million
Previous $3.75 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$11.39 - $22.17 $329,227 - $640,823
-28,905 Reduced 12.43%
203,607 $3.75 Million
Q1 2025

May 12, 2025
SELL
$10.59 - $20.83 $40,835 - $80,320
-3,856 Reduced 1.63%
232,512 $2.46 Million
Q4 2024

Feb 12, 2025
SELL
$14.82 - $25.48 $301,557 - $518,467
-20,348 Reduced 7.93%
236,368 $4.01 Million
Q3 2024

Dec 26, 2024
SELL
$18.08 - $25.38 $276,461 - $388,085
-15,291 Reduced 5.62%
256,716 $5.96 Million
Q3 2024

Nov 08, 2024
SELL
$18.08 - $25.38 $276,461 - $388,085
-15,291 Reduced 5.62%
256,716 $5.96 Million
Q2 2024

Dec 26, 2024
BUY
$24.35 - $44.39 $372,335 - $678,767
15,291 Added 5.96%
272,007 $6.62 Million
Q2 2024

Aug 12, 2024
SELL
$24.35 - $44.39 $1.11 Million - $2.02 Million
-45,544 Reduced 14.34%
272,007 $6.62 Million
Q1 2024

Dec 26, 2024
BUY
$31.23 - $42.99 $1.9 Million - $2.62 Million
60,835 Added 23.7%
317,551 $10.7 Million
Q1 2024

May 10, 2024
SELL
$31.23 - $42.99 $164,519 - $226,471
-5,268 Reduced 1.63%
317,551 $10.7 Million
Q4 2023

Dec 26, 2024
BUY
$17.71 - $32.97 $1.17 Million - $2.18 Million
66,103 Added 25.75%
322,819 $10.2 Million
Q4 2023

Feb 12, 2024
SELL
$17.71 - $32.97 $85,539 - $159,245
-4,830 Reduced 1.47%
322,819 $10.2 Million
Q3 2023

Nov 14, 2023
SELL
$25.44 - $37.35 $276,609 - $406,106
-10,873 Reduced 3.21%
327,649 $8.37 Million
Q2 2023

Aug 11, 2023
SELL
$23.94 - $32.36 $79,432 - $107,370
-3,318 Reduced 0.97%
338,522 $9.71 Million
Q1 2023

May 18, 2023
BUY
$14.72 - $23.97 $260,617 - $424,388
17,705 Added 5.46%
341,840 $8.19 Million
Q1 2023

May 11, 2023
SELL
$14.72 - $23.97 $280,298 - $456,436
-19,042 Reduced 5.55%
324,135 $7.77 Million
Q4 2022

Feb 13, 2023
SELL
$14.14 - $23.06 $42,052 - $68,580
-2,974 Reduced 0.86%
343,177 $5.82 Million
Q3 2022

Nov 14, 2022
BUY
$13.05 - $22.13 $275,237 - $466,743
21,091 Added 6.49%
346,151 $5.13 Million
Q2 2022

Aug 11, 2022
SELL
$12.26 - $31.17 $919 - $2,337
-75 Reduced 0.02%
325,060 $5.12 Million
Q1 2022

May 11, 2022
SELL
$17.64 - $39.57 $519,356 - $1.17 Million
-29,442 Reduced 8.3%
325,135 $8.77 Million
Q4 2021

Feb 10, 2022
BUY
$34.2 - $47.56 $4.13 Million - $5.74 Million
120,744 Added 51.64%
354,577 $13.1 Million
Q3 2021

Nov 12, 2021
BUY
$27.88 - $58.25 $6.52 Million - $13.6 Million
233,833 New
233,833 $11.2 Million

Others Institutions Holding ARCT

# of Institutions
173
Shares Held
26M
Call Options Held
2.32M
Put Options Held
866K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $193M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email